Hydroxychloroquine: what you need to know
The Briefing · LiSTNR
Audio is streamed directly from the publisher (enrichment.soundstack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Hydroxychloroquine is the drug at the centre of public debate and Donald Trump has revealed he’s been taking it to try and reduce his chances of getting Covid-19. Professor Marc Pellegrini (Walter & Eliza Hall institute of Medical Research) is the lead researcher on the Australian trial and joins us on today's show.
In today's news headlines:
- Bushfire royal commission hears black summer “not a one-off”
- Court rules Celeste Barber’s $51 million NSW RFS fundraiser can’t go to other charities
- Preventing male suicide a focus of $20 million mental health package
- Top medical body demands urgent information campaign after Pete Evans anti-vaxxer interview
In today's Briefing we ask: How dangerous are the side effects? What are the risks of taking it to prevent COVID-19? What does Australia hope to achieve with their trial? Why are populist right wing leaders latching on to Hydroxychloroquine as a COVID-19 solution?
See omnystudio.com/listener for privacy information.